| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.ANTIVIRAL.2015.05.008 |
| P698 | PubMed publication ID | 26022197 |
| P2093 | author name string | Rui Liu | |
| Wei Tang | |||
| Xiaoyu Li | |||
| Ge Liu | |||
| Xulin Chen | |||
| Liwei An | |||
| P2860 | cites work | Mammalian innate resistance to highly pathogenic avian influenza H5N1 virus infection is mediated through reduced proinflammation and infectious virus release | Q39327655 |
| Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo | Q39530571 | ||
| A new shield for a cytokine storm. | Q40449457 | ||
| Long-term maintenance of mature pulmonary parenchyma cultured in serum-free conditions | Q41127955 | ||
| Enhanced infectivity of H5N1 highly pathogenic avian influenza (HPAI) virus in pig ex vivo respiratory tract organ cultures following adaptation by in vitro passage | Q42268309 | ||
| Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury | Q43182443 | ||
| IFN-gamma treatment at early stages of influenza virus infection protects mice from death in a NK cell-dependent manner | Q45377967 | ||
| The prostanoid 15-deoxy-Δ12,14-prostaglandin-j2 reduces lung inflammation and protects mice against lethal influenza infection | Q83180001 | ||
| A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS | Q107473800 | ||
| A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays | Q28145712 | ||
| Interferon-γ: an overview of signals, mechanisms and functions | Q28207081 | ||
| Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia | Q28262914 | ||
| Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus | Q28283850 | ||
| Green Tea Catechin, Epigallocatechin Gallate, Suppresses Signaling by the dsRNA Innate Immune Receptor RIG-I | Q28475559 | ||
| LPS-induced lung inflammation in marmoset monkeys - an acute model for anti-inflammatory drug testing | Q28482881 | ||
| Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection | Q28748904 | ||
| Treating influenza with statins and other immunomodulatory agents. | Q30351911 | ||
| Genomic profiling of tumor necrosis factor alpha (TNF-alpha) receptor and interleukin-1 receptor knockout mice reveals a link between TNF-alpha signaling and increased severity of 1918 pandemic influenza virus infection | Q30394612 | ||
| Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo | Q30406177 | ||
| Comparison of ribavirin and oseltamivir in reducing mortality and lung injury in mice infected with mouse adapted A/California/04/2009 (H1N1) | Q30412126 | ||
| Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series | Q33360515 | ||
| Replication of avian, human and swine influenza viruses in porcine respiratory explants and association with sialic acid distribution | Q33692187 | ||
| Infection of differentiated porcine airway epithelial cells by influenza virus: differential susceptibility to infection by porcine and avian viruses | Q34103067 | ||
| Germacrone inhibits early stages of influenza virus infection | Q34375472 | ||
| An overview of real-time quantitative PCR: applications to quantify cytokine gene expression | Q34532446 | ||
| Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice | Q35784934 | ||
| Human lung innate immune response to Bacillus anthracis spore infection | Q35949826 | ||
| Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice | Q36949482 | ||
| Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets | Q36949775 | ||
| A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection | Q37148404 | ||
| Inhibition of p38 mitogen-activated protein kinase impairs influenza virus-induced primary and secondary host gene responses and protects mice from lethal H5N1 infection | Q37428595 | ||
| Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology | Q37455968 | ||
| Innate immune response to H3N2 and H1N1 influenza virus infection in a human lung organ culture model | Q37463506 | ||
| Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea. | Q37727183 | ||
| Exploring lung physiology in health and disease with lung slices | Q37877938 | ||
| Immunomodulatory therapy for severe influenza | Q37910249 | ||
| Precision cut lung slices as an efficient tool for in vitro lung physio-pharmacotoxicology studies | Q38048927 | ||
| Screening and identification of inhibitors against influenza A virus from a US drug collection of 1280 drugs | Q38980481 | ||
| P304 | page(s) | 101-111 | |
| P577 | publication date | 2015-05-27 | |
| P1433 | published in | Antiviral Research | Q4775352 |
| P1476 | title | Mouse lung slices: An ex vivo model for the evaluation of antiviral and anti-inflammatory agents against influenza viruses | |
| P478 | volume | 120 |
| Q33557579 | Berberine Restricts Coxsackievirus B Type 3 Replication via Inhibition of c-Jun N-Terminal Kinase (JNK) and p38 MAPK Activation In Vitro. |
| Q91927859 | Lupeol alleviates coxsackievirus B3-induced viral myocarditis in mice via downregulating toll-like receptor 4 |
| Q47648337 | Modeling tuberculosis pathogenesis through ex vivo lung tissue infection. |
| Q92560151 | Precision cut lung slices: a novel versatile tool to examine host-pathogen interaction in the chicken lung |
| Q51352696 | Regioselective construction of diverse and multifunctionalized 2-hydroxybenzophenones for sun protection by indium(iii)-catalyzed benzannulation. |
| Q57020780 | Use of Precision-Cut Lung Slices as an Tool for Evaluating Viruses and Viral Vectors for Gene and Oncolytic Therapy |
| Q99237820 | Where We Stand: Lung Organotypic Living Systems That Emulate Human-Relevant Host-Environment/Pathogen Interactions |
Search more.